Appraisal of Beneficial Effects of Oral Supplementation with Folic Acid during Curative Chemo-Radiation for Head and Neck Cancer: An Observational Study

Rao Suresh, H.T.D. Sanath, Rao Pratima, D’silva Prajna, Katherin D’souza Rhea, Ponadka Rai Manoj, Shrinath Baliga Manjeshwar
{"title":"Appraisal of Beneficial Effects of Oral Supplementation with Folic Acid during Curative Chemo-Radiation for Head and Neck Cancer: An Observational Study","authors":"Rao Suresh, H.T.D. Sanath, Rao Pratima, D’silva Prajna, Katherin D’souza Rhea, Ponadka Rai Manoj, Shrinath Baliga Manjeshwar","doi":"10.46619/cmj.2019.2-1014","DOIUrl":null,"url":null,"abstract":"Background: In people undergoing curative radiation treatment to the head and neck region the local effects like mucositis, dysphasia, dermatitis, salivary dysfunction and systemic effects like anaemia and leucopoenia are major issues. Folic acid is always provided when a patient has anaemia and is also regularly used in the care of cancer patients. However, literature study indicates that the quantum of beneficial effects of folic acid supplementing to patients undergoing curative radiotherapy are lacking. In lieu of these observations the present study was conducted to ascertain the beneficial effect of folic acid supplementation to head and neck cancer (HNC) patients undergoing curative radiotherapy. Methods: This was an observational study and was carried out in HNC patients planned for curative radiotherapy. The folic acid levels were estimated at the start of the study. Patients who had folic acid less than 20 ng/ml were prescribed folic acid (5 mg TID) for the first two weeks. The incidence of mucositis, dysphasia, dermatitis, salivary dysfunction, anaemia and leucopoenia were analysed at the end of the study. For analysis we studied what is the effect in people who had folic acid less than and, above 5 ng/ml and analysed the results using the X2 analysis. Results: The results indicated that there was a significant difference (p = 0.03) was seen in the incidence of leukopenia in the volunteers who had less than 5 ng/ml of folic acid. A significant difference in the incidence of severe dermatitis (P = 0.04) and in weight loss (P = 0.02) was also observed. Conclusions: The study findings suggest that when compared to the patients who had folic acid less than 5 ng/ml, administering folic acid was beneficial in mitigating dermatitis, weight loss and leucopenia in people with folic acid above 5 ng/ml. More studies are required to ascertain the benefit of folic acid.","PeriodicalId":72513,"journal":{"name":"Cancer medicine journal","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer medicine journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46619/cmj.2019.2-1014","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Background: In people undergoing curative radiation treatment to the head and neck region the local effects like mucositis, dysphasia, dermatitis, salivary dysfunction and systemic effects like anaemia and leucopoenia are major issues. Folic acid is always provided when a patient has anaemia and is also regularly used in the care of cancer patients. However, literature study indicates that the quantum of beneficial effects of folic acid supplementing to patients undergoing curative radiotherapy are lacking. In lieu of these observations the present study was conducted to ascertain the beneficial effect of folic acid supplementation to head and neck cancer (HNC) patients undergoing curative radiotherapy. Methods: This was an observational study and was carried out in HNC patients planned for curative radiotherapy. The folic acid levels were estimated at the start of the study. Patients who had folic acid less than 20 ng/ml were prescribed folic acid (5 mg TID) for the first two weeks. The incidence of mucositis, dysphasia, dermatitis, salivary dysfunction, anaemia and leucopoenia were analysed at the end of the study. For analysis we studied what is the effect in people who had folic acid less than and, above 5 ng/ml and analysed the results using the X2 analysis. Results: The results indicated that there was a significant difference (p = 0.03) was seen in the incidence of leukopenia in the volunteers who had less than 5 ng/ml of folic acid. A significant difference in the incidence of severe dermatitis (P = 0.04) and in weight loss (P = 0.02) was also observed. Conclusions: The study findings suggest that when compared to the patients who had folic acid less than 5 ng/ml, administering folic acid was beneficial in mitigating dermatitis, weight loss and leucopenia in people with folic acid above 5 ng/ml. More studies are required to ascertain the benefit of folic acid.
头颈癌化疗放疗期间口服补充叶酸的有益效果评价:一项观察性研究
背景:在头颈部接受根治性放射治疗的患者中,粘膜炎、吞咽不良、皮炎、唾液功能障碍等局部效应和贫血、白细胞减少等全身效应是主要问题。当患者患有贫血时,通常会提供叶酸,也经常用于癌症患者的护理。然而,文献研究表明,叶酸补充对接受治疗性放疗的患者的有益作用的量是缺乏的。为了替代这些观察结果,本研究旨在确定补充叶酸对接受治疗性放疗的头颈癌(HNC)患者的有益作用。方法:这是一项观察性研究,在HNC患者计划治疗性放疗中进行。叶酸水平是在研究开始时估计的。叶酸低于20 ng/ml的患者在前两周服用叶酸(5 mg TID)。研究结束时分析了粘膜炎、吞咽不良、皮炎、唾液功能障碍、贫血和白细胞减少的发生率。为了分析,我们研究了叶酸低于和高于5纳克/毫升的人的影响,并使用X2分析分析了结果。结果:叶酸含量低于5 ng/ml的志愿者白细胞减少率有显著差异(p = 0.03)。严重皮炎的发生率(P = 0.04)和体重减轻(P = 0.02)也有显著差异。结论:研究结果表明,与叶酸低于5 ng/ml的患者相比,叶酸高于5 ng/ml的患者给予叶酸有利于减轻皮炎,体重减轻和白细胞减少。需要更多的研究来确定叶酸的益处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信